Retinal vasoproliferative tumor (Retinal reactive astrocytic tumor).
Crespo Carballés MJ, Sastre-Ibáñez M, Prieto Del Cura M, Jimeno Anaya L, Pastora N, Quijada Angeli S.
J Fr Ophtalmol. 2019 Dec;42(10):e455-e458. doi: 10.1016/j.jfo.2019.05.033. Epub 2019 Jul 8.
Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.
Shirahata M, Ono T, Stichel D, Schrimpf D, Reuss DE, Sahm F, Koelsche C, Wefers A, Reinhardt A, Huang K, Sievers P, Shimizu H, Nanjo H, Kobayashi Y, Miyake Y, Suzuki T, Adachi JI, Mishima K, Sasaki A, Nishikawa R, Bewerunge-Hudler M, Ryzhova M, Absalyamova O, Golanov A, Sinn P, Platten M, Jungk C, Winkler F, Wick A, Hänggi D, Unterberg A, Pfister SM, Jones DTW, van den Bent M, Hegi M, French P, Baumert BG, Stupp R, Gorlia T, Weller M, Capper D, Korshunov A, Herold-Mende C, Wick W, Louis DN, von Deimling A.
Acta Neuropathol. 2018 Jul;136(1):153-166. doi: 10.1007/s00401-018-1849-4. Epub 2018 Apr 23.
Anaplastic astrocytoma.
Grimm SA, Chamberlain MC.
CNS Oncol. 2016 Jul;5(3):145-57. doi: 10.2217/cns-2016-0002. Epub 2016 May 27.
Astrocytic tumors.
Riemenschneider MJ, Reifenberger G.
Recent Results Cancer Res. 2009;171:3-24. doi: 10.1007/978-3-540-31206-2_1.
Malignant Astrocytic Tumor Progression Potentiated by JAK-mediated Recruitment of Myeloid Cells.
Rajappa P, Cobb WS, Vartanian E, Huang Y, Daly L, Hoffman C, Zhang J, Shen B, Yanowitch R, Garg K, Cisse B, Haddock S, Huse J, Pisapia DJ, Chan TA, Lyden DC, Bromberg JF, Greenfield JP.
Clin Cancer Res. 2017 Jun 15;23(12):3109-3119. doi: 10.1158/1078-0432.CCR-16-1508. Epub 2016 Dec 30.
Pediatric astrocytic tumor grading: comparison between arterial spin labeling and dynamic susceptibility contrast MRI perfusion.
Morana G, Tortora D, Staglianò S, Nozza P, Mascelli S, Severino M, Piatelli G, Consales A, Lequin M, Garrè ML, Rossi A.
Neuroradiology. 2018 Apr;60(4):437-446. doi: 10.1007/s00234-018-1992-6. Epub 2018 Feb 16.
Hypoxia in astrocytic tumors and implications for therapy.
Cavazos DA, Brenner AJ.
Neurobiol Dis. 2016 Jan;85:227-233. doi: 10.1016/j.nbd.2015.06.007. Epub 2015 Jun 19.
HNK-1 glycan functions as a tumor suppressor for astrocytic tumor.
Suzuki-Anekoji M, Suzuki M, Kobayashi T, Sato Y, Nakayama J, Suzuki A, Bao X, Angata K, Fukuda M.
J Biol Chem. 2011 Sep 16;286(37):32824-33. doi: 10.1074/jbc.M111.245886. Epub 2011 Jul 22.
Clinical significance of CD133 and Nestin in astrocytic tumor: The correlation with pathological grade and survival.
Zhang Q, Xu B, Chen J, Chen F, Chen Z.
J Clin Lab Anal. 2020 Mar;34(3):e23082. doi: 10.1002/jcla.23082. Epub 2019 Nov 1.
Role of GalNAc4S-6ST in astrocytic tumor progression.
Kobayashi T, Yan H, Kurahashi Y, Ito Y, Maeda H, Tada T, Hongo K, Nakayama J.
PLoS One. 2013;8(1):e54278. doi: 10.1371/journal.pone.0054278. Epub 2013 Jan 17.
